http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112015008931-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a0923a18811784dc87c206262266d224
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C319-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C227-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
filingDate 2013-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0310d586b7343ce37bcb332714b41a60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_727b4b86c649b74d242042466eda93bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd5674b47e71e7e8e7c974bd27a99a86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_feb3e9d7eafca427a59757ebbcf4b91b
publicationDate 2021-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-112015008931-B1
titleOfInvention CRYSTALLINE FORM OF (3S,3S) 4,4-DISULPHANDIYLBIS(3-AMINOBUTANE 1-SULPHONIC ACID) OF ABSD; PROCESS FOR THE PREPARATION OF A CRYSTALLINE FORM OF ABSD AND L-LYSINE; AND PHARMACEUTICAL COMPOSITION
abstract (3s,3s') 4,4'-disulfanediylbis (3-aminobutane 1-sulfonic acid) crystalline form of absd; process for preparing a crystalline form of absd and l-lysine; and pharmaceutical composition the present invention relates to a new crystalline phase of (3s,3s') 4,4'-disulfanediylbis (3-aminobutane 1-sulfonic acid) (absd) with l-lysine and its use, particularly in the pharmaceutical industry , and processes for its preparation. the invention is also directed to pharmaceutical compositions containing at least one crystalline phase of (3s,3s') 4,4'-disulfanediylbis (3-aminobutane 1-sulfonic acid) (absd) with l-lysine and to therapeutic or prophylactic use of such a crystalline phase and compositions comprising the same.
priorityDate 2012-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ48677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557733
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86590530
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397080
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ07075
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID859558
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422529505
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7140381
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449561317
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16211825
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP50123
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421904295
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9951180
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCNP_031960
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID64017
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ32LQ0
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10013250
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537902
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20285768
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460972
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5962
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0DQU2
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421896767
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556976
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460928
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57449
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485577
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6322
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ95334
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP16406
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460920
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13809
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID866
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454005604

Total number of triples: 78.